Stay updated with breaking news from Membrane Type. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Bicycle Therapeutics plc (NASDAQ:BCYC – Get Free Report) have earned an average recommendation of “Moderate Buy” from the seven ratings firms that are presently covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a hold rating and six have assigned a buy rating to the company. The average 12 […]
Shares of Bicycle Therapeutics plc (NASDAQ:BCYC – Get Free Report) have been given an average rating of “Moderate Buy” by the seven brokerages that are presently covering the firm, Marketbeat.com reports. One research analyst has rated the stock with a hold rating and six have issued a buy rating on the company. The average 1 […]
Bicycle Therapeutics plc (NASDAQ:BCYC – Get Free Report) insider Nigel Crockett sold 2,643 shares of the business’s stock in a transaction dated Wednesday, January 3rd. The shares were sold at an average price of $17.50, for a total value of $46,252.50. Following the completion of the transaction, the insider now directly owns 48,716 shares of […]
AtonRa Partners lessened its position in Bicycle Therapeutics plc (NASDAQ:BCYC – Free Report) by 18.5% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 11,588 shares of the company’s stock after selling 2,631 shares during the period. AtonRa Partners’ holdings in Bicycle Therapeutics were worth […]
Shares of Bicycle Therapeutics plc (NASDAQ:BCYC – Get Free Report) gapped down prior to trading on Friday following insider selling activity. The stock had previously closed at $17.46, but opened at $16.96. Bicycle Therapeutics shares last traded at $16.73, with a volume of 20,461 shares. Specifically, CEO Kevin Lee sold 8,703 shares of the firm’s […]